Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Mid-Cap · Fidelity

Fidelity Flex Mid Cap Focused Index Fund (FXMCX)

Ticker FXMCX · Index fund · · Holdings as of Jul 31, 2026

Expense ratio
0%$0/yr per $10k
Net assets
$19.8Mall share classes
Holdings
406

Bottom line

Is FXMCX a good fund? The bottom line

FXMCX is an index mid-cap mutual fund from Fidelity.

Annual fees run 0% — about $0 a year on every $10,000 invested, cheaper than 99% of mid-cap funds we track.

With $19.8 million in net assets and 406 holdings, its largest position is Astera Labs Inc (1.3%) and the top 10 make up 6.8% of the portfolio.

What stands out

  • Low cost: cheaper than 99% of mid-cap peers
  • Broadly diversified (406 holdings)

What to watch

  • Small fund ($19.8 million) — small funds are likelier to close
  • High turnover (135% a year) can mean more taxable distributions

Updated Nov 19, 2026

What FXMCX invests in

Fidelity Flex Mid Cap Focused Index Fund seeks to provide investment results that correspond to the total return of stocks of mid-capitalization U.S. companies.

Normally investing at least 80% of assets in securities of mid-capitalization companies included in the Fidelity U.S. Mid Cap Focused IndexSM. The Fidelity U.S. Mid Cap Focused Index SM is designed to reflect the performance of stocks of mid-capitalization U.S. companies. Mid-capitalization stocks are considered to be stocks whose market capitalization is similar to the market capitalization of companies in the Russell Midcap Index or the S&P MidCap 400 Index. The Fidelity U.S. Mid Cap Focused Index SM was created by Fidelity Product Services LLC (FPS) using a rules-based proprietary index methodology that includes all U.S. stocks meeting certain market capitalization, liquidity and investability requirements. Derivative instruments that provide investment exposure to the investments above or exposure to one or more market risk factors associated with such investments are included in…

From the fund's prospectus (filed Jun 24, 2026).

What FXMCX costs

On a $10,000 investment, FXMCX's 0% expense ratio costs about $0 a year. The median mid-cap fund charges 0.88%.

See the full FXMCX fee table →

FXMCX top 10 holdings

#Holding% of fund
1Astera Labs Inc1.29%
2Everpure Inc0.71%
3Guardant Health Inc0.70%
4Affirm Holdings Inc0.67%
5Tenet Healthcare Corp0.66%
6Roku Inc0.61%
7Viking Holdings Ltd0.60%
8Lattice Semiconductor Corp0.54%
9Wesco International Inc0.53%
10Rbc Bearings Inc0.52%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 6.8% of the fund. See all top 25 holdings and asset mix →

Alternatives to FXMCX

More funds like FXMCX →

FXMCX FAQ

What is the expense ratio of FXMCX?
FXMCX's expense ratio is 0%, which works out to about $0 a year for every $10,000 invested.
Is FXMCX a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 99% of mid-cap peers; broadly diversified (406 holdings); small fund ($19.8 million) — small funds are likelier to close; high turnover (135% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does FXMCX hold?
FXMCX's largest holdings are Astera Labs Inc (1.3%), Everpure Inc (0.7%), Guardant Health Inc (0.7%), Affirm Holdings Inc (0.7%), Tenet Healthcare Corp (0.7%). It holds 406 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
Who manages FXMCX?
FXMCX is offered by Fidelity through Fidelity Salem Street Trust.